SIC 2833 – Medicinal Chemicals and Botanical Products
Valuation | |
---|---|
Market Cap ($M) | 684.23 |
Enterprise Value ($M) | 598.65 |
Book Value ($M) | 78.13 |
Book Value / Share | 1.09 |
Price / Book | 8.76 |
NCAV ($M) | 57.47 |
NCAV / Share | 0.80 |
Price / NCAV | 11.91 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.04 |
Return on Assets (ROA) | -0.62 |
Return on Equity (ROE) | -0.73 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 3.22 |
Current Ratio | 3.22 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 103.87 |
Assets | 124.54 |
Liabilities | 46.41 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -93.87 |
Net Income | -95.73 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -64.36 |
Cash from Investing | 0.00 |
Cash from Financing | 21.85 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Commodore Capital Lp | 8.30 | ||
13G | Deep Track Capital, LP | 9.49 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
260,415 | 1,036,870 | 25.12 | |
227,534 | 140,369 | 162.10 | |
204,985 | 268,268 | 76.41 | |
315,697 | 222,164 | 142.10 | |
369,353 | 268,025 | 137.81 | |
(click for more detail) |
Similar Companies | |
---|---|
MGTX – MeiraGTx Holdings plc | MIST – Milestone Pharmaceuticals Inc. |
MLYS – Mineralys Therapeutics, Inc. | MRNA – Moderna, Inc. |
MRSN – Mersana Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io